Aducanumab FDA Approval for Alzheimer's Disease: The Importance of G…

Anton Porsteinsson

Differentiating Early Signs of Alzheimer Disease From Normal Signs o…

ACHL

J. Galvin

Lewy Body Dementia: The Most Common Disease You Never Heard Of

University of Miami

J. Galvin

Cognitive Disorders

ZINCARE

M. Mataa

Gut Microbiome and the Brain

BRAIN PONDERINGS podcast with Mark Mattson

J. Cryan

Early Diagnosis of Alzheimer’s Disease

Sharon Cohen

New & Emerging Treatments in Alzheimer's Disease

University of Miami

E. Crocco

AAIC 2024 Insights: Effects of Gut Microbiota Dysbiosis on Cognitive…

AAIC 2024 Insights Hub

Y. (Laura) Zhang

Updates in Dementia

2023 Conference Coverage

P. Tipton

AAIC 2024 Insights: Potential of Targeting the Alpha-1 Adrenergic Re…

AAIC 2024 Insights Hub

S. G. Pattanashetty

Alzheimer's: Clinical Pearls

Lawrence Robbins

Lewy Body Dementia: The Most Common Disease You Never Heard Of - 2024

AdventHealth

J. Galvin

AAIC 2024 Insights: Developing an AI Algorithm to Detect Predictors …

AAIC 2024 Insights Hub

J. Butler

The Illusion of Progress: Lecanemab in Alzheimer's Disease

Alberto Espay

AAIC 2024 Insights: qEEG as Biomarker for Alzheimer's Disease - Inve…

AAIC 2024 Insights Hub

C. Simfukwe

Frontotemporal Dementias and Selective Neuronal Vulnerability

BRAIN PONDERINGS podcast with Mark Mattson

W. Seeley, M. Mattson

A New Era for Brain Health in Primary Care: New Drugs and Diagnostics

University of Kansas Medical Center

J. M. Burns

AAIC 2024 Insights: Plasma Aβ42/Aβ40 and Phospho-Tau217 Concentratio…

AAIC 2024 Insights Hub

R. Rissman

Demystifying Dementia: Differentiating the Most Common Dementias

University of Kansas Medical Center

R. Townley

An Update on Alzheimer's Disease: New Strategies Across the Disease …

Miller Medical Communications

P. Tariot